Displaying 1 to 20 of 34 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Achaogen Inc Develops solutions to the problem of drug resistance |
United States | 1 Apr 2010 | Series C Active |
|
|
|
Achaogen Inc Develops solutions to the problem of drug resistance |
United States | 10 Oct 2006 | Series B Active |
|
|
Alexza Pharmaceuticals Inc |
United States | N/A Initial investment. Round participant. Active |
||
|
Ambrx Inc A clinical stage biopharmaceutical company with a broad biologics platform that allows it to create best-in-class protein therapeutics. |
United States | 1 Apr 2009 | Series D Active |
|
|
|
Anaphore Inc Developing a novel class of protein therapeutics, Atrimers, to address significant unmet medical needs in immune-mediated diseases and oncology. |
United States | 1 Jan 2008 | N/A USD 3,300,000 (USD 3,300,000) deal size. |
|
|
|
Ceterix Orthopedics Inc Develops technologies to address unmet clinical needs in arthroscopic surgery |
United States | 1 Oct 2010 | Series A |
|
|
|
Cleave Biosciences Inc Drug development company focused on novel targets in cellular protein homeostasis pathways |
United States | 11 Nov 2011 | Series A Active |
|
|
|
DVS Sciences Inc An analytical instrument and reagents company founded in Toronto |
United States | 14 Jul 2011 | Series A |
|
|
|
Envoy Therapeutics Inc A platform CNS drug discovery company spun out of decades of work at the Rockefeller University |
United States | N/A |
||
|
|
Flexion Therapeutics Inc Discovers and develops innovative therapeutics for musculoskeletal disorders |
United States | 19 Oct 2009 | Series A |
|
|
|
Fourteen22 A biopharmaceutical company, focused on developing biosimilar monoclonal antibodies |
United States | N/A |
||
|
|
Igenica Inc A monoclonal-antibody discovery and development company |
United States | 10 Jun 2010 | Series B |
|
|
|
Ikaria Inc Developer of innovative therapeutics and interventions to meet the significant needs of critically ill patients |
United States | N/A |
||
|
|
Ilypsa Inc Discover and develop new polymer-based therapeutics |
United States | N/A |
||
|
|
Incline Therapeutics Inc Patient controlled analgesia |
United States | 1 Jun 2010 | Series A |
|
|
|
KaloBios Pharmaceuticals Inc Develops first- or best-in-class antibody therapeutics in the fields of autoimmunity |
United States | N/A |
||
|
|
Kinestral Technologies Inc Industrial biotechnology company developing novel new chemistry applied to building materials for energy efficiency. |
United States | N/A |
||
|
|
Marcadia Biotech Inc A peptide therapeutics company |
United States | 1 Mar 2006 | Venture Active |
|
|
|
Miikana Therapeutics Inc A clinically-driven oncology company founded out of the former Amgen Institute |
United States | N/A |
||
|
|
Panomics Inc Develops novel cell-based assays and tools to enable multiplexed measurements of molecular events in a quantitative and scalable manner |
United States | N/A |